← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Fulgent Genetics FLGT $565M	–	–	–	–
102	FRLN 102 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
103	103 DELISTED Generation Bio GBIO	–	–	–	–
104	104 CytoMed Therapeutics GDTC $10M	–	–	–	–
105	105 Guardant Health GH $21.3B	–	–	–	–
106	GMDA 106 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
107	107 Corgi Genomics & Precision Medicine ETF GNMX $1.64M	–	–	–	–
108	108 Global X Genomics & Biotechnology ETF GNOM $96.7M	–	–	–	–
109	109 Genprex GNPX $1.84M	–	–	–	–
110	110 Genenta Science GNTA $32.3M	–	–	–	–
111	111 GRAIL Inc GRAL $5.49B	–	–	–	–
112	GRCL 112 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
113	GRML 113 Greenland Mines Ltd GRML $87.4M	–	–	–	–
114	GTH 114 DELISTED Genetron Holdings Limited ADS GTH	–	–	–	–
115	115 Fractyl Health GUTS $27.2M	–	–	–	–
116	116 Franklin Genomic Advancements ETF HELX $29.8M	–	–	–	–
117	HTGM 117 DELISTED HTG Molecular Diagnostics, Inc. Common Stock HTGM	–	–	–	–
118	118 iShares Genomics Immunology and Healthcare ETF IDNA $309M	–	–	–	–
119	119 Immix Biopharma IMMX $706M	–	–	–	–
120	120 Immatics IMTX $1.06B	–	–	–	–
121	121 IN8bio INAB $11.5M	–	–	–	–
122	122 MiNK Therapeutics INKT $50.5M	–	–	–	–
123	123 INmune Bio INMB $44.7M	–	–	–	–
124	124 Century Therapeutics IPSC $268M	–	–	–	–
125	KRBP 125 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–